ESTERN Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

ESTERN Medical is a privately held, US-based CRO founded in 2017 (with historical references to 2002) and headquartered in Irvine, California, with a corporate office in Cambridge, Massachusetts. It provides end-to-end clinical trial services across North and Latin America, leveraging its regional footprint to serve sponsors interested in these markets. The company emphasizes its dynamic approach, strategic advisory boards, and partnerships to fuel growth in the competitive CRO landscape.

Medical DevicesDrug Delivery

Technology Platform

Integrated clinical trial service platform for North and Latin America, encompassing operational infrastructure, regulatory advisory, and regional expertise for Phase I-IV trials.

Opportunities

Capitalizing on the significant trend of conducting FDA-regulated clinical trials outside the U.S., particularly in Latin America's cost-effective and patient-rich markets.

Growth through strategic advisory board expansion and forming alliances with global pharma, biotech, and medtech companies seeking regional expertise.

Risk Factors

Intense competition from larger global CROs and niche players.

Operational and reputational risk from trial execution failures or compliance issues.

Geographic concentration risk due to heavy focus on Latin American markets, which can be susceptible to economic and regulatory volatility.

Competitive Landscape

Operates in the highly competitive global CRO market, competing against large players (e.g., IQVIA, PPD, ICON) and smaller regional firms. Differentiates itself as a mid-sized, agile CRO with deep, integrated expertise specifically in conducting trials across the United States and Latin America, offering a personalized alternative to larger, more standardized providers.

More companies in United States →